US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist

0.771
+0.023+3.09%

Trading Nov 27 13:14 ET

50.80MMarket Cap-597P/E (TTM)

IO Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-30.13%-20.81M

7.01%-16.98M

-69.72%-24.93M

-20.10%-71.74M

-81.98%-22.8M

-19.79%-15.99M

-40.36%-18.26M

29.52%-14.69M

-46.95%-59.73M

34.90%-12.53M

Net income from continuing operations

-10.78%-24.02M

2.32%-20.69M

-14.16%-19.46M

-20.47%-86.08M

-30.45%-26.18M

-38.19%-21.68M

-14.51%-21.18M

0.93%-17.04M

-5.27%-71.46M

5.81%-20.07M

Operating gains losses

-576.61%-1.63M

1,000.00%90K

279.07%462K

-154.62%-331K

22.41%-405K

293.10%342K

-103.51%-10K

-1,390.00%-258K

59.25%-130K

-4,250.00%-522K

Depreciation and amortization

5.67%205K

14.44%214K

21.26%211K

40.00%756K

5.79%201K

63.03%194K

1,600.00%187K

-20.91%174K

26,900.00%540K

9,400.00%190K

Deferred tax

----

--0

----

--87K

----

Change In working capital

36.32%2.95M

57.58%1.76M

-1,502.73%-7.72M

39.84%5.86M

-66.83%2.03M

910.49%2.16M

-70.89%1.12M

110.00%550K

640.21%4.19M

470.14%6.13M

-Change in prepaid assets

352.41%846K

-195.12%-760K

-210.21%-2.08M

-65.75%1.57M

-237.11%-1.31M

-91.71%187K

-68.10%799K

266.23%1.89M

156.59%4.58M

125.08%954K

-Change in payables and accrued expense

10.45%2.32M

475.22%2.67M

-1,190.63%-4.69M

2,514.78%4.9M

-39.98%2.71M

184.72%2.1M

-77.29%464K

91.52%-363K

-102.77%-203K

-8.10%4.51M

-Change in other current assets

-318.18%-48K

135.71%5K

0.00%-792K

90.91%-4K

8.94%780K

0.00%22K

98.19%-14K

-8,700.00%-792K

-76.00%-44K

--716K

-Change in other current liabilities

-15.60%-163K

-17.16%-157K

16.22%-155K

-334.53%-604K

-200.00%-144K

-98.59%-141K

-343.64%-134K

-146.67%-185K

---139K

---48K

Cash from discontinued investing activities

Operating cash flow

-30.13%-20.81M

7.01%-16.98M

-69.72%-24.93M

-20.10%-71.74M

-81.98%-22.8M

-19.79%-15.99M

-40.36%-18.26M

29.52%-14.69M

-46.95%-59.73M

34.90%-12.53M

Investing cash flow

Cash flow from continuing investing activities

58.33%-10K

69.23%-12K

92.57%-11K

53.19%-323K

67.91%-112K

79.66%-24K

63.55%-39K

-27.59%-148K

-350.98%-690K

-132.67%-349K

Net PPE purchase and sale

58.33%-10K

69.23%-12K

92.57%-11K

53.19%-323K

67.91%-112K

79.66%-24K

63.55%-39K

-27.59%-148K

-350.98%-690K

-132.67%-349K

Cash from discontinued investing activities

Investing cash flow

58.33%-10K

69.23%-12K

92.57%-11K

53.19%-323K

67.91%-112K

79.66%-24K

63.55%-39K

-27.59%-148K

-350.98%-690K

-132.67%-349K

Financing cash flow

Cash flow from continuing financing activities

71.86M

-10K

Net common stock issuance

----

--75.06M

--0

----

--0

Net other financing activities

----

---3.2M

---10K

----

Cash from discontinued financing activities

Financing cash flow

--0

--71.86M

---10K

--71.87M

--0

Net cash flow

Beginning cash position

-8.47%101.02M

-8.19%118.25M

0.42%143.46M

-32.55%142.86M

9.46%165.77M

-35.23%110.36M

-31.55%128.8M

-32.55%142.86M

6,120.23%211.8M

232.99%151.44M

Current changes in cash

-137.27%-20.82M

7.14%-16.99M

-68.10%-24.94M

99.67%-200K

-78.00%-22.92M

514.79%55.86M

-39.51%-18.3M

29.21%-14.84M

-128.48%-60.42M

-107.66%-12.88M

Effect of exchange rate changes

156.89%256K

-83.97%-241K

-134.58%-268K

109.42%803K

-85.83%609K

91.80%-450K

97.19%-131K

129.06%775K

-126.77%-8.52M

334.68%4.3M

End cash Position

-51.47%80.45M

-8.47%101.02M

-8.19%118.25M

0.42%143.46M

9.46%165.77M

-35.23%110.36M

-31.55%128.8M

-32.55%142.86M

Free cash flow

-30.00%-20.82M

7.14%-16.99M

-68.10%-24.94M

-19.27%-72.06M

-77.92%-22.91M

-18.92%-16.01M

-39.51%-18.3M

29.21%-14.84M

-48.09%-60.42M

33.60%-12.88M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-30.13%-20.81M	7.01%-16.98M	-69.72%-24.93M	-20.10%-71.74M	-81.98%-22.8M	-19.79%-15.99M	-40.36%-18.26M	29.52%-14.69M	-46.95%-59.73M	34.90%-12.53M
Net income from continuing operations	-10.78%-24.02M	2.32%-20.69M	-14.16%-19.46M	-20.47%-86.08M	-30.45%-26.18M	-38.19%-21.68M	-14.51%-21.18M	0.93%-17.04M	-5.27%-71.46M	5.81%-20.07M
Operating gains losses	-576.61%-1.63M	1,000.00%90K	279.07%462K	-154.62%-331K	22.41%-405K	293.10%342K	-103.51%-10K	-1,390.00%-258K	59.25%-130K	-4,250.00%-522K
Depreciation and amortization	5.67%205K	14.44%214K	21.26%211K	40.00%756K	5.79%201K	63.03%194K	1,600.00%187K	-20.91%174K	26,900.00%540K	9,400.00%190K
Deferred tax	----	----	----	--0	----	----	----	----	--87K	----
Change In working capital	36.32%2.95M	57.58%1.76M	-1,502.73%-7.72M	39.84%5.86M	-66.83%2.03M	910.49%2.16M	-70.89%1.12M	110.00%550K	640.21%4.19M	470.14%6.13M
-Change in prepaid assets	352.41%846K	-195.12%-760K	-210.21%-2.08M	-65.75%1.57M	-237.11%-1.31M	-91.71%187K	-68.10%799K	266.23%1.89M	156.59%4.58M	125.08%954K
-Change in payables and accrued expense	10.45%2.32M	475.22%2.67M	-1,190.63%-4.69M	2,514.78%4.9M	-39.98%2.71M	184.72%2.1M	-77.29%464K	91.52%-363K	-102.77%-203K	-8.10%4.51M
-Change in other current assets	-318.18%-48K	135.71%5K	0.00%-792K	90.91%-4K	8.94%780K	0.00%22K	98.19%-14K	-8,700.00%-792K	-76.00%-44K	--716K
-Change in other current liabilities	-15.60%-163K	-17.16%-157K	16.22%-155K	-334.53%-604K	-200.00%-144K	-98.59%-141K	-343.64%-134K	-146.67%-185K	---139K	---48K
Cash from discontinued investing activities
Operating cash flow	-30.13%-20.81M	7.01%-16.98M	-69.72%-24.93M	-20.10%-71.74M	-81.98%-22.8M	-19.79%-15.99M	-40.36%-18.26M	29.52%-14.69M	-46.95%-59.73M	34.90%-12.53M
Investing cash flow
Cash flow from continuing investing activities	58.33%-10K	69.23%-12K	92.57%-11K	53.19%-323K	67.91%-112K	79.66%-24K	63.55%-39K	-27.59%-148K	-350.98%-690K	-132.67%-349K
Net PPE purchase and sale	58.33%-10K	69.23%-12K	92.57%-11K	53.19%-323K	67.91%-112K	79.66%-24K	63.55%-39K	-27.59%-148K	-350.98%-690K	-132.67%-349K
Cash from discontinued investing activities
Investing cash flow	58.33%-10K	69.23%-12K	92.57%-11K	53.19%-323K	67.91%-112K	79.66%-24K	63.55%-39K	-27.59%-148K	-350.98%-690K	-132.67%-349K
Financing cash flow
Cash flow from continuing financing activities				71.86M	-10K				0	0
Net common stock issuance	----	----	----	--75.06M	--0	----	----	----	--0	--0
Net other financing activities	----	----	----	---3.2M	---10K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	--0	--0	--71.86M	---10K	--71.87M	--0	--0	--0	--0
Net cash flow
Beginning cash position	-8.47%101.02M	-8.19%118.25M	0.42%143.46M	-32.55%142.86M	9.46%165.77M	-35.23%110.36M	-31.55%128.8M	-32.55%142.86M	6,120.23%211.8M	232.99%151.44M
Current changes in cash	-137.27%-20.82M	7.14%-16.99M	-68.10%-24.94M	99.67%-200K	-78.00%-22.92M	514.79%55.86M	-39.51%-18.3M	29.21%-14.84M	-128.48%-60.42M	-107.66%-12.88M
Effect of exchange rate changes	156.89%256K	-83.97%-241K	-134.58%-268K	109.42%803K	-85.83%609K	91.80%-450K	97.19%-131K	129.06%775K	-126.77%-8.52M	334.68%4.3M
End cash Position	-51.47%80.45M	-8.47%101.02M	-8.19%118.25M	0.42%143.46M	0.42%143.46M	9.46%165.77M	-35.23%110.36M	-31.55%128.8M	-32.55%142.86M	-32.55%142.86M
Free cash flow	-30.00%-20.82M	7.14%-16.99M	-68.10%-24.94M	-19.27%-72.06M	-77.92%-22.91M	-18.92%-16.01M	-39.51%-18.3M	29.21%-14.84M	-48.09%-60.42M	33.60%-12.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data